An Australian biotech company is already turning heads so far on Wednesday after it was announced results from its GBM-AGILE, which is a phase II/III study that included an...

To read the full story on AllPennyStocks.com, click here.

Kazia Therapeutics (NASDAQ:KZIA)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024 Haga Click aquí para más Gráficas Kazia Therapeutics.
Kazia Therapeutics (NASDAQ:KZIA)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024 Haga Click aquí para más Gráficas Kazia Therapeutics.